RACHEL TENNIS: Open Payments
NPI 1023519980 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,580 in 149 payments from 18 companies in 2025. Trend: 2023 $1,455 · 2024 $4,699 · 2025 $3,580
Food & beverage: $3,305Education: $275
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $892 |
| ABBVIE INC. | 22 | $420 |
| UCB, Inc. | 18 | $342 |
| Arcutis Biotherapeutics, Inc. | 12 | $293 |
| Galderma Laboratories, L.P. | 15 | $283 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $271 |
| Regeneron Healthcare Solutions, Inc. | 8 | $218 |
| PFIZER INC. | 12 | $192 |
| Amgen Inc. | 8 | $150 |
| GENZYME CORPORATION | 5 | $112 |
Products named: TREMFYA, Bimzelx, DUPIXENT, Zoryve, SKYRIZI, NEMLUVIO, CIBINQO, Otezla.
Industry payments across NV — which companies pay providers there.
